References
- BrownGCShieldsJASanbornGAugsburgerJJSavinoPJSchatzNJRadiation retinopathyOphthalmology198289149415017162794
- WaraWMIrvineARNegerREHowesELJrPhillipsTLRadiation retinopathyInt J Radiat Oncol Biol Phys197958183422419
- IrvineARAlvaradoJAWaraWMMorrisBWWoodISRadiation retinopathy: An experimental model for the ischemic-proliferative retinopathiesTrans Am Ophthalmol Soc1981791031227342397
- MissottenGSNottingICSchlingemannROVascular endothelial growth factor A in eyes with uveal melanomaArch Ophthalmol20061241428143417030710
- BoydSRTanDBunceCVascular endothelial growth factor is elevated in ocular fluids of eyes harbouring uveal melanoma: identification of a potential therapeutic windowBr J Ophthalmol20028636836911914199
- ShieldsCLDemirciHDaiVIntravitreal triamcinolone acetonide for radiation maculopathy after plaque radiotherapy for choroidal melanomaRetina20052586887416205566
- FingerPTRadiation retinopathy is treatable with anti-vascular endothelial growth factor bevacizumab (Avastin)Int J Radiat Oncol Biol Phys200815;70497497718313522
- MasonJO3rdAlbertMAJrPersaudTOVailRSIntravitreal bevacizumab treatment for radiation macular edema after plaque radiotherapy for choroidal melanomaRetina200727790390717891015